rs73069703

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_130837.3(OPA1):​c.2049A>G​(p.Val683Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00253 in 1,613,918 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 34 hom. )

Consequence

OPA1
NM_130837.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.280

Publications

7 publications found
Variant links:
Genes affected
OPA1 (HGNC:8140): (OPA1 mitochondrial dynamin like GTPase) The protein encoded by this gene is a nuclear-encoded mitochondrial protein with similarity to dynamin-related GTPases. The encoded protein localizes to the inner mitochondrial membrane and helps regulate mitochondrial stability and energy output. This protein also sequesters cytochrome c. Mutations in this gene have been associated with optic atrophy type 1, which is a dominantly inherited optic neuropathy resulting in progressive loss of visual acuity, leading in many cases to legal blindness. [provided by RefSeq, Aug 2017]
OPA1 Gene-Disease associations (from GenCC):
  • autosomal dominant optic atrophy, classic form
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • optic atrophy
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • OPA1-related optic atrophy with or without extraocular features
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • Behr syndrome
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant optic atrophy plus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 3-193654898-A-G is Benign according to our data. Variant chr3-193654898-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95716.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.28 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00737 (1122/152314) while in subpopulation AFR AF = 0.0218 (907/41578). AF 95% confidence interval is 0.0206. There are 10 homozygotes in GnomAd4. There are 541 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_130837.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPA1
NM_130837.3
MANE Select
c.2049A>Gp.Val683Val
synonymous
Exon 22 of 31NP_570850.2
OPA1
NM_130836.3
c.1995A>Gp.Val665Val
synonymous
Exon 21 of 30NP_570849.2
OPA1
NM_130835.3
c.1941A>Gp.Val647Val
synonymous
Exon 21 of 30NP_570848.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPA1
ENST00000361510.8
TSL:5 MANE Select
c.2049A>Gp.Val683Val
synonymous
Exon 22 of 31ENSP00000355324.2
OPA1
ENST00000361908.8
TSL:1
c.1995A>Gp.Val665Val
synonymous
Exon 21 of 30ENSP00000354681.3
OPA1
ENST00000361715.6
TSL:5
c.1941A>Gp.Val647Val
synonymous
Exon 21 of 30ENSP00000355311.2

Frequencies

GnomAD3 genomes
AF:
0.00736
AC:
1120
AN:
152196
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.0185
Gnomad SAS
AF:
0.00848
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00445
AC:
1116
AN:
250932
AF XY:
0.00408
show subpopulations
Gnomad AFR exome
AF:
0.0193
Gnomad AMR exome
AF:
0.00264
Gnomad ASJ exome
AF:
0.00377
Gnomad EAS exome
AF:
0.0204
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000159
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.00202
AC:
2959
AN:
1461604
Hom.:
34
Cov.:
31
AF XY:
0.00217
AC XY:
1578
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.0210
AC:
701
AN:
33460
American (AMR)
AF:
0.00315
AC:
141
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00345
AC:
90
AN:
26124
East Asian (EAS)
AF:
0.0223
AC:
885
AN:
39634
South Asian (SAS)
AF:
0.00867
AC:
748
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53378
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5760
European-Non Finnish (NFE)
AF:
0.000121
AC:
135
AN:
1111898
Other (OTH)
AF:
0.00409
AC:
247
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
152
305
457
610
762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00737
AC:
1122
AN:
152314
Hom.:
10
Cov.:
32
AF XY:
0.00726
AC XY:
541
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0218
AC:
907
AN:
41578
American (AMR)
AF:
0.00346
AC:
53
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.0185
AC:
96
AN:
5188
South Asian (SAS)
AF:
0.00849
AC:
41
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68014
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
55
110
164
219
274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00368
Hom.:
2
Bravo
AF:
0.00819
Asia WGS
AF:
0.0220
AC:
77
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
not specified (2)
-
-
1
Autosomal dominant optic atrophy classic form (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
2.0
DANN
Benign
0.68
PhyloP100
-0.28
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73069703; hg19: chr3-193372687; API